Reviews Ortho Evra


No reviews yet.

Ortho Evra Drug Description
ORTHO EVRA®
(norelgestromin/ethinyl estradiol) Transdermal System
Patients should be counseled that this product does not protect against
HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION



What are the possible side effects of ethinyl estradiol and norelgestromin (Ortho Evra)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using the patches and call your doctor at once if you have any of these serious side effects:

sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling,...
Read All Potential Side Effects for Ortho Evra »




ORTHO EVRA® is a combination transdermal contraceptive patch with a contact
surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN)
and 0.75 mg ethinyl estradiol (EE). Systemic exposures (as measured by area
under the curve [AUC] and steady state concentration [Css]) of NGMN and EE during
use of ORTHO EVRA® are higher and peak concentrations (Cmax) are lower than
those produced by an oral contraceptive containing norgestimate 250 mcg / EE
35 mcg. (See BOLDED WARNING; CLINICAL
PHARMACOLOGY, Transdermal versus Oral Contraceptives).
ORTHO EVRA®is a thin, matrix-type transdermal contraceptive patch consisting of three layers. The backing layer is composed of a beige flexible film consisting of a low-density pigmented polyethylene outer layer and a polyester inner layer. It provides structural support and protects the middle adhesive layer from the environment. The middle layer contains polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric and lauryl lactate as inactive components. The active components in this layer are the hormones, norelgestromin and ethinyl estradiol. The third layer is the release liner, which protects the adhesive layer during storage and is removed just prior to application. It is a transparent polyethylene terephthalate (PET) film with a polydimethylsiloxane coating on the side that is in contact with the middle adhesive layer.
The outside of the backing layer is heat-stamped “ORTHO EVRA®.”
The structural formulas of the components are:








Molecular weight, norelgestromin: 327.47
Molecular weight, ethinyl estradiol: 296.41
Chemical name for norelgestromin: 18, 19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-
17-hydroxy-, 3-oxime, (17α)
Chemical name for ethinyl estradiol: 19-Norpregna-1, 3, 5 (10)-trien-20-yne-3,
17-diol, (17α)Last reviewed on RxList: 4/30/2010




Ortho Evra Drug Description
ORTHO EVRA®
(norelgestromin/ethinyl estradiol) Transdermal System
Patients should be counseled that this product does not protect against
HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION



What are the possible side effects of ethinyl estradiol and norelgestromin (Ortho Evra)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using the patches and call your doctor at once if you have any of these serious side effects:

sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling,...
Read All Potential Side Effects for Ortho Evra »




ORTHO EVRA® is a combination transdermal contraceptive patch with a contact
surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN)
and 0.75 mg ethinyl estradiol (EE). Systemic exposures (as measured by area
under the curve [AUC] and steady state concentration [Css]) of NGMN and EE during
use of ORTHO EVRA® are higher and peak concentrations (Cmax) are lower than
those produced by an oral contraceptive containing norgestimate 250 mcg / EE
35 mcg. (See BOLDED WARNING; CLINICAL
PHARMACOLOGY, Transdermal versus Oral Contraceptives).
ORTHO EVRA®is a thin, matrix-type transdermal contraceptive patch consisting of three layers. The backing layer is composed of a beige flexible film consisting of a low-density pigmented polyethylene outer layer and a polyester inner layer. It provides structural support and protects the middle adhesive layer from the environment. The middle layer contains polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric and lauryl lactate as inactive components. The active components in this layer are the hormones, norelgestromin and ethinyl estradiol. The third layer is the release liner, which protects the adhesive layer during storage and is removed just prior to application. It is a transparent polyethylene terephthalate (PET) film with a polydimethylsiloxane coating on the side that is in contact with the middle adhesive layer.
The outside of the backing layer is heat-stamped “ORTHO EVRA®.”
The structural formulas of the components are:








Molecular weight, norelgestromin: 327.47
Molecular weight, ethinyl estradiol: 296.41
Chemical name for norelgestromin: 18, 19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-
17-hydroxy-, 3-oxime, (17α)
Chemical name for ethinyl estradiol: 19-Norpregna-1, 3, 5 (10)-trien-20-yne-3,
17-diol, (17α)Last reviewed on RxList: 4/30/2010




Ortho Evra Drug Description
ORTHO EVRA®
(norelgestromin/ethinyl estradiol) Transdermal System
Patients should be counseled that this product does not protect against
HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION



What are the possible side effects of ethinyl estradiol and norelgestromin (Ortho Evra)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using the patches and call your doctor at once if you have any of these serious side effects:

sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling,...
Read All Potential Side Effects for Ortho Evra »




ORTHO EVRA® is a combination transdermal contraceptive patch with a contact
surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN)
and 0.75 mg ethinyl estradiol (EE). Systemic exposures (as measured by area
under the curve [AUC] and steady state concentration [Css]) of NGMN and EE during
use of ORTHO EVRA® are higher and peak concentrations (Cmax) are lower than
those produced by an oral contraceptive containing norgestimate 250 mcg / EE
35 mcg. (See BOLDED WARNING; CLINICAL
PHARMACOLOGY, Transdermal versus Oral Contraceptives).
ORTHO EVRA®is a thin, matrix-type transdermal contraceptive patch consisting of three layers. The backing layer is composed of a beige flexible film consisting of a low-density pigmented polyethylene outer layer and a polyester inner layer. It provides structural support and protects the middle adhesive layer from the environment. The middle layer contains polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric and lauryl lactate as inactive components. The active components in this layer are the hormones, norelgestromin and ethinyl estradiol. The third layer is the release liner, which protects the adhesive layer during storage and is removed just prior to application. It is a transparent polyethylene terephthalate (PET) film with a polydimethylsiloxane coating on the side that is in contact with the middle adhesive layer.
The outside of the backing layer is heat-stamped “ORTHO EVRA®.”
The structural formulas of the components are:








Molecular weight, norelgestromin: 327.47
Molecular weight, ethinyl estradiol: 296.41
Chemical name for norelgestromin: 18, 19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-
17-hydroxy-, 3-oxime, (17α)
Chemical name for ethinyl estradiol: 19-Norpregna-1, 3, 5 (10)-trien-20-yne-3,
17-diol, (17α)Last reviewed on RxList: 4/30/2010




Ortho Evra Drug Description
ORTHO EVRA®
(norelgestromin/ethinyl estradiol) Transdermal System
Patients should be counseled that this product does not protect against
HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION



What are the possible side effects of ethinyl estradiol and norelgestromin (Ortho Evra)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using the patches and call your doctor at once if you have any of these serious side effects:

sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling,...
Read All Potential Side Effects for Ortho Evra »




ORTHO EVRA® is a combination transdermal contraceptive patch with a contact
surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN)
and 0.75 mg ethinyl estradiol (EE). Systemic exposures (as measured by area
under the curve [AUC] and steady state concentration [Css]) of NGMN and EE during
use of ORTHO EVRA® are higher and peak concentrations (Cmax) are lower than
those produced by an oral contraceptive containing norgestimate 250 mcg / EE
35 mcg. (See BOLDED WARNING; CLINICAL
PHARMACOLOGY, Transdermal versus Oral Contraceptives).
ORTHO EVRA®is a thin, matrix-type transdermal contraceptive patch consisting of three layers. The backing layer is composed of a beige flexible film consisting of a low-density pigmented polyethylene outer layer and a polyester inner layer. It provides structural support and protects the middle adhesive layer from the environment. The middle layer contains polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric and lauryl lactate as inactive components. The active components in this layer are the hormones, norelgestromin and ethinyl estradiol. The third layer is the release liner, which protects the adhesive layer during storage and is removed just prior to application. It is a transparent polyethylene terephthalate (PET) film with a polydimethylsiloxane coating on the side that is in contact with the middle adhesive layer.
The outside of the backing layer is heat-stamped “ORTHO EVRA®.”
The structural formulas of the components are:








Molecular weight, norelgestromin: 327.47
Molecular weight, ethinyl estradiol: 296.41
Chemical name for norelgestromin: 18, 19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-
17-hydroxy-, 3-oxime, (17α)
Chemical name for ethinyl estradiol: 19-Norpregna-1, 3, 5 (10)-trien-20-yne-3,
17-diol, (17α)Last reviewed on RxList: 4/30/2010




Ortho Evra Drug Description
ORTHO EVRA®
(norelgestromin/ethinyl estradiol) Transdermal System
Patients should be counseled that this product does not protect against
HIV infection (AIDS) and other sexually transmitted diseases.
DRUG DESCRIPTION



What are the possible side effects of ethinyl estradiol and norelgestromin (Ortho Evra)?

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Stop using the patches and call your doctor at once if you have any of these serious side effects:

sudden numbness or weakness, especially on one side of the body;
sudden headache, confusion, pain behind the eyes, problems with vision, speech, or balance;
chest pain or heavy feeling,...
Read All Potential Side Effects for Ortho Evra »




ORTHO EVRA® is a combination transdermal contraceptive patch with a contact
surface area of 20 cm2. It contains 6.00 mg norelgestromin (NGMN)
and 0.75 mg ethinyl estradiol (EE). Systemic exposures (as measured by area
under the curve [AUC] and steady state concentration [Css]) of NGMN and EE during
use of ORTHO EVRA® are higher and peak concentrations (Cmax) are lower than
those produced by an oral contraceptive containing norgestimate 250 mcg / EE
35 mcg. (See BOLDED WARNING; CLINICAL
PHARMACOLOGY, Transdermal versus Oral Contraceptives).
ORTHO EVRA®is a thin, matrix-type transdermal contraceptive patch consisting of three layers. The backing layer is composed of a beige flexible film consisting of a low-density pigmented polyethylene outer layer and a polyester inner layer. It provides structural support and protects the middle adhesive layer from the environment. The middle layer contains polyisobutylene/polybutene adhesive, crospovidone, non-woven polyester fabric and lauryl lactate as inactive components. The active components in this layer are the hormones, norelgestromin and ethinyl estradiol. The third layer is the release liner, which protects the adhesive layer during storage and is removed just prior to application. It is a transparent polyethylene terephthalate (PET) film with a polydimethylsiloxane coating on the side that is in contact with the middle adhesive layer.
The outside of the backing layer is heat-stamped “ORTHO EVRA®.”
The structural formulas of the components are:








Molecular weight, norelgestromin: 327.47
Molecular weight, ethinyl estradiol: 296.41
Chemical name for norelgestromin: 18, 19-dinorpregn-4-en-20-yn-3-one, 13-ethyl-
17-hydroxy-, 3-oxime, (17α)
Chemical name for ethinyl estradiol: 19-Norpregna-1, 3, 5 (10)-trien-20-yne-3,
17-diol, (17α)Last reviewed on RxList: 4/30/2010





Other reviews about Ortho Evra on wordpress

Ortho-Evra Birth Control Patch Warnings
  by voidptr
The FDA has issued a warning about Ortho-Evra, the birth control patch. Apparently, since the hormones are absorbed through the skin instead of the digestive system like the […]


Ortho Evra Warnings Issued
  by Rachel
CNN has a story today, Warning issued about birth control patch. There is concern about increased risk of blood clots in women using the patch compared to those […]


Ortho Evra
  by greatdane
There is a fairly new form of birth control on the market now - its called Ortho Evra.  It's actually a pretty cool idea in theory - its […]


Ortho Evra Users - The Verdict Is In!
  by heremias
The FDA today announced that it has approved that Ortho McNeil, the manufacturer of the Ortho Evra Contraceptive Transdermal Patch make some changes to the medication's label. The […]


Contraceptive Patch Label Updated to Address Blood Clot Risks
  by Rachel
The label for the contraceptive patch Ortho Evra was updated yesterday as a result of a study that suggested that women using the patch were at higher risk […]


Ortho-Evra exposes women to dangerous estrogen levels, Public Citizen tells FDA
  by Maureen Backman
When Johnson & Johnson received approval from the FDA in November 2001 for Ortho-Evra, a contraceptive patch, the company claimed its product would have two key advantages over […]


Johnson & Johnson Paid $68.7 Million to Settle Ortho Evra Lawsuits
  by Eric Dinnocenzo
There is a good post on feministing.com about the recent settlement for at least $68.7 by Johnson & Johnson of hundreds of Ortho Evra lawsuits.  The dosage of estrogen […]


Ortho Evra Patch Birth Control Patch – the best non invasive contraceptive
  by cheapusameds
I being a female know that what a headache using a contraceptive can be. Not only they invade our sex life but sometimes they may have some effect […]


Did Johnson & Johnson Bury Data on Ortho-Evra's Health Risks?
  by Meredith Melnick
It's should be common knowledge that the Johnson & Johnson (J&J) Ortho-Evra birth-control patch has more risks than the birth control pill (it's on the label) — because […]


Study: An IUD May Treat Endometrial Cancer and Preserve Fertility in Young Women
  by Meredith Melnick
A new study finds that intrauterine devices (IUD), which are traditionally used as contraceptives, could help treat early stage endometrial cancer in women who wish to preserve their […]



Other reviews about Ortho Evra on web:

ORTHO EVRA, as effective as the Pill but even simpler. ORTHO EVRA, the Patch


On November 10, 2005 Ortho McNeil, in conjunction with the FDA, revised the label for Ortho Evra, including a new bolded warning about higher exposure to estrogen for women using ... Contraceptive patch - Wikipedia, the free encyclopedia


Learn about the prescription medication Ortho Evra (Norelgestromin, Ethinyl Estradiol), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Ortho Evra (Norelgestromin, Ethinyl Estradiol) Drug Information ...


ORTHO EVRA, as effective as the Pill but even simpler. ORTHO EVRA – Questions About the Patch


Ortho Evra skin patches (ethinyl estradiol and norelgestromin) are used as a contraceptive to prevent pregnancy. Includies Ortho Evra side effects, interactions and indications. Ortho Evra Information from Drugs.com


The Nations Law Firm represents those injured by the Ortho Evra patch. Our attorneys will evaluate your case free of charge. Updated Ortho Evra information and news links on site Ortho Evra Birth Control Patch Lawsuits | Howard L. Nations ...


Birth Control Patch at a Glance. A small patch that sticks to your skin to prevent pregnancy ; Safe, effective, and convenient ; Easy to get with a prescription Birth Control Patch - Ortho Evra


Accurate, FDA approved Ortho Evra information for healthcare professionals and patients - brought to you by Drugs.com. Ortho Evra Official FDA information, side effects and uses.


Learn about Ortho Evra on eHow.com. Find info and videos including: Pregnancy & Ortho Evra, How to Use Ortho Evra, Effectiveness of Ortho Evra and much more. Ortho Evra - eHow.com


Side Effects of Ortho Evra. Ortho Evra is commonly known as the birth control patch contraceptive method. Women who take Ortho Evra apply the birth control patch once a week, three ... Side Effects of Ortho Evra | eHow.com





Featured Reviews

Reviews Tev-Tropin

Tev-Tropin Drug Description TEV-TROPIN® [somatropin (rDNA origin)]  for Injection5 mg (15 IU) DRUG DESCRIPTION What are the possible side effects of somatropin? If you have Prader-Willi syndrome, call your doctor promptly...
Read More  |  Review This
Reviews Provigil

Provigil Drug Description PROVIGIL® (modafinil) Tablets [C-IV] DRUG DESCRIPTION What are the possible side effects of modafinil (Provigil)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Indomethacin Inj

Indocin IV Drug Description Indocin® I.V. (indomethacin) for Injection Sterile DRUG DESCRIPTION Sterile INDOCIN® I.V. (indomethacin for injection) for intravenous administration is lyophilized indomethacin for injection. Each vial...
Read More  |  Review This
Reviews Zolpidem Tartrate Oral Spray

Zolpimist Drug Description Zolpimist (zolpidem tartrate) Oral Spray DRUG DESCRIPTION Zolpimist contains zolpidem tartrate, a non-benzodiazepine hypnotic of the imidazopyridine class. Chemically, zolpidem is N,N,6-trimethyl-2-p-tolylimidazo[1,2-a] ...
Read More  |  Review This
Reviews Atrovent Nasal Spray

Atrovent Nasal Spray Drug Description Atrovent® (ipratropium bromide) Nasal Spray 0.03% DRUG DESCRIPTION What are the possible side effects of ipratropium nasal (Atrovent Nasal)? Stop using ipratropium nasal and get emergency...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....